Gauthier Remiche

Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial

Jordi Díaz‐Manera, Priya S. Kishnani, Hani Kushlaf et al. · The Lancet Neurology · 2021 · 169 citations · Full text

Late-onset Pompe Disease, Autoimmune Disease, Clinical Infectious Disease +3

Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weakness

Ana Töpf, Katherine Johnson, Adam Bates et al. · Genetics in Medicine · 2020 · 105 citations · Full text

Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 sera

Émilien Delmont, Alexandre Brodovitch, Ludivine Kouton et al. · Journal of Neurology · 2020 · 103 citations · Full text

Rheumatology, Medical Diagnostics, Allergy +10

Screening for later-onset Pompe's disease in patients with paucisymptomatic hyperCKemia

Marco Spada, Francesco Porta, Liliana Vercelli et al. · Molecular Genetics and Metabolism · 2013 · 57 citations

Later-onset Pompe, Clinical Epidemiology, Hematology +2

Impact of hyponatremia on nerve conduction and muscle strength

Frédéric Vandergheynst, Yannick Gombeir, Flavio Bellante et al. · European Journal of Clinical Investigation · 2016 · 46 citations